Cheng-Pin Chen
Overview
Explore the profile of Cheng-Pin Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng S, Yang Y, Chen C, Hsieh H, Lin Y, Cheng C, et al.
PLoS One
. 2024 Dec;
19(12):e0304045.
PMID: 39739827
Few studies have demonstrated the interplay between human immunodeficiency virus (HIV), anal human papillomavirus (HPV), and anal microbiota, especially in persons living with HIV who are men who have sex...
2.
Wu J, Lin Y, Lee S, Chen C, Cheng S, Cheng C, et al.
Glob Chall
. 2024 Dec;
8(12):2400124.
PMID: 39679287
Healthcare-associated infection (HAI) is the most common adverse medical event that affects patients. Internationally, healthcare workers (HCWs) are monitored for hand hygiene compliance to reduce HAI risk. While direct observation...
3.
Lee S, Lin Y, Chen C, Cheng S, Chang S, Ku S, et al.
PLoS One
. 2024 Nov;
19(11):e0314003.
PMID: 39565750
Conflicting data exists regarding the baseline determinants of virological nonsuppression outcomes in treatment-experienced people living with human immunodeficiency virus (PWH) switching to antiretroviral treatment (ART) with bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF)...
4.
Chen J, Lin Y, Chen C, Cheng S, Hu H, Yeh H, et al.
J Microbiol Immunol Infect
. 2024 Nov;
PMID: 39562192
The proportion of trough plasma concentration of dolutegravir (DTG) above protein adjusted 90 % inhibition concentration (IC90) (0.064 mg/L) was 98.1 % across all visits during the twelve doses of...
5.
Chen X, Mohapatra A, Nguyen H, Schimanski L, Tan T, Rijal P, et al.
PLoS Pathog
. 2024 Jun;
20(6):e1012246.
PMID: 38857264
Antibody-mediated immunity plays a key role in protection against SARS-CoV-2. We characterized B-cell-derived anti-SARS-CoV-2 RBD antibody repertoires from vaccinated and infected individuals and elucidate the mechanism of action of broadly...
6.
Liu W, Feng P, Cheng C, Chou C, Lee C, Lu M, et al.
Infect Dis Ther
. 2024 May;
13(7):1575-1588.
PMID: 38771550
Introduction: Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon. This clinical study aimed to evaluate its antiviral efficacy of ropeginterferon alfa-2b against SARS-CoV-2 infection. Methods: This is a multicenter, randomized, open-label...
7.
Axfors C, Schmitt A, Janiaud P, Vant Hooft J, Abd-Elsalam S, Abdo E, et al.
Nat Commun
. 2024 Feb;
15(1):1075.
PMID: 38316844
No abstract available.
8.
Paulose A, Hou Y, Huang Y, Chakkalaparambil Dileep N, Chiu C, Pal A, et al.
Anal Chem
. 2023 Apr;
95(17):6871-6878.
PMID: 37080900
In this study, a rapid diagnosis platform was developed for the detection of O157:H7. An electrical double layer (EDL)-gated field-effect transistor-based biosensor (BioFET) as a point-of-care testing device is demonstrated...
9.
Huang Y, Hsu F, Wu J, Lin Y, Liu M, Yang C, et al.
J Microbiol Immunol Infect
. 2023 Mar;
56(3):506-515.
PMID: 36967265
Background: Understanding the neutralizing antibody (NAb) titer against COVID-19 over time is important to provide information for vaccine implementation. The longitudinal NAb titer over one year after SARS-CoV-2 infection is...
10.
Chao T, Lee W, Hu H, Lin Y, Ho S, Chen H, et al.
J Clin Virol Plus
. 2023 Jan;
3(1):100133.
PMID: 36594045
Although real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR) remains as a golden standard for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, it can not be easily...